Trials / Completed
CompletedNCT03046836
Oxytocin, Alcohol Craving, and Intimate Partner Aggression
Effects of Oxytocin on Alcohol Craving and Intimate Partner Aggression
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Medical University of South Carolina · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Alcohol use disorders (AUD) and intimate partner aggression (IPA) frequently co-occur. There are significant health and economic burdens associated with AUD and co-occurring IPA, and little empirical data to guide treatment efforts. The neuropeptide oxytocin may help mitigate both AUD and IPA. However, clinical data examining oxytocin's effects on human aggression is scant. The proposed study is designed to address these gaps in the literature by utilizing a human laboratory paradigm to test the effects of oxytocin on craving and aggression among couples with AUD and co-occurring IPA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxytocin | 40 IU oxytocin nasal spray |
| DRUG | Placebo | Saline |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2021-04-11
- Completion
- 2021-04-11
- First posted
- 2017-02-08
- Last updated
- 2022-05-09
- Results posted
- 2022-05-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03046836. Inclusion in this directory is not an endorsement.